Codeine Phosphate Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512242909

Publication Date:

December 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Codeine phosphate injection, used for analgesia, mainly moderate or above pain can be used for sedation, in addition, cough suppressant, used for severe dry cough, because of its addictive nature, belongs to the special controlled drugs.
The global market for Codeine Phosphate Injection was estimated to be worth US$ 14 million in 2023 and is forecast to a readjusted size of US$ 19 million by 2030 with a CAGR of 3.8% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Codeine Phosphate Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Codeine Phosphate Injection by region & country, by Type, and by Application.
The Codeine Phosphate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine Phosphate Injection.
Market Segmentation
By Company
Nepharm
Humanwell Pharma
Segment by Type:
15mg
30mg
Segment by Application
Narcotic Analgesic
Antitussive
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Codeine Phosphate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Codeine Phosphate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Codeine Phosphate Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Codeine Phosphate Injection Product Introduction
1.2 Global Codeine Phosphate Injection Market Size Forecast
1.2.1 Global Codeine Phosphate Injection Sales Value (2019-2030)
1.2.2 Global Codeine Phosphate Injection Sales Volume (2019-2030)
1.2.3 Global Codeine Phosphate Injection Sales Price (2019-2030)
1.3 Codeine Phosphate Injection Market Trends & Drivers
1.3.1 Codeine Phosphate Injection Industry Trends
1.3.2 Codeine Phosphate Injection Market Drivers & Opportunity
1.3.3 Codeine Phosphate Injection Market Challenges
1.3.4 Codeine Phosphate Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Codeine Phosphate Injection Players Revenue Ranking (2023)
2.2 Global Codeine Phosphate Injection Revenue by Company (2019-2024)
2.3 Global Codeine Phosphate Injection Players Sales Volume Ranking (2023)
2.4 Global Codeine Phosphate Injection Sales Volume by Company Players (2019-2024)
2.5 Global Codeine Phosphate Injection Average Price by Company (2019-2024)
2.6 Key Manufacturers Codeine Phosphate Injection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Codeine Phosphate Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Codeine Phosphate Injection
2.9 Codeine Phosphate Injection Market Competitive Analysis
2.9.1 Codeine Phosphate Injection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Codeine Phosphate Injection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine Phosphate Injection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 15mg
3.1.2 30mg
3.2 Global Codeine Phosphate Injection Sales Value by Type
3.2.1 Global Codeine Phosphate Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Codeine Phosphate Injection Sales Value, by Type (2019-2030)
3.2.3 Global Codeine Phosphate Injection Sales Value, by Type (%) (2019-2030)
3.3 Global Codeine Phosphate Injection Sales Volume by Type
3.3.1 Global Codeine Phosphate Injection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Codeine Phosphate Injection Sales Volume, by Type (2019-2030)
3.3.3 Global Codeine Phosphate Injection Sales Volume, by Type (%) (2019-2030)
3.4 Global Codeine Phosphate Injection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Narcotic Analgesic
4.1.2 Antitussive
4.1.3 Others
4.2 Global Codeine Phosphate Injection Sales Value by Application
4.2.1 Global Codeine Phosphate Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Codeine Phosphate Injection Sales Value, by Application (2019-2030)
4.2.3 Global Codeine Phosphate Injection Sales Value, by Application (%) (2019-2030)
4.3 Global Codeine Phosphate Injection Sales Volume by Application
4.3.1 Global Codeine Phosphate Injection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Codeine Phosphate Injection Sales Volume, by Application (2019-2030)
4.3.3 Global Codeine Phosphate Injection Sales Volume, by Application (%) (2019-2030)
4.4 Global Codeine Phosphate Injection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Codeine Phosphate Injection Sales Value by Region
5.1.1 Global Codeine Phosphate Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Codeine Phosphate Injection Sales Value by Region (2019-2024)
5.1.3 Global Codeine Phosphate Injection Sales Value by Region (2025-2030)
5.1.4 Global Codeine Phosphate Injection Sales Value by Region (%), (2019-2030)
5.2 Global Codeine Phosphate Injection Sales Volume by Region
5.2.1 Global Codeine Phosphate Injection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Codeine Phosphate Injection Sales Volume by Region (2019-2024)
5.2.3 Global Codeine Phosphate Injection Sales Volume by Region (2025-2030)
5.2.4 Global Codeine Phosphate Injection Sales Volume by Region (%), (2019-2030)
5.3 Global Codeine Phosphate Injection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Codeine Phosphate Injection Sales Value, 2019-2030
5.4.2 North America Codeine Phosphate Injection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Codeine Phosphate Injection Sales Value, 2019-2030
5.5.2 Europe Codeine Phosphate Injection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Codeine Phosphate Injection Sales Value, 2019-2030
5.6.2 Asia Pacific Codeine Phosphate Injection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Codeine Phosphate Injection Sales Value, 2019-2030
5.7.2 South America Codeine Phosphate Injection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Codeine Phosphate Injection Sales Value, 2019-2030
5.8.2 Middle East & Africa Codeine Phosphate Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Codeine Phosphate Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Codeine Phosphate Injection Sales Value
6.2.1 Key Countries/Regions Codeine Phosphate Injection Sales Value, 2019-2030
6.2.2 Key Countries/Regions Codeine Phosphate Injection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Codeine Phosphate Injection Sales Value, 2019-2030
6.3.2 United States Codeine Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Codeine Phosphate Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Codeine Phosphate Injection Sales Value, 2019-2030
6.4.2 Europe Codeine Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Codeine Phosphate Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Codeine Phosphate Injection Sales Value, 2019-2030
6.5.2 China Codeine Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Codeine Phosphate Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Codeine Phosphate Injection Sales Value, 2019-2030
6.6.2 Japan Codeine Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Codeine Phosphate Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Codeine Phosphate Injection Sales Value, 2019-2030
6.7.2 South Korea Codeine Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Codeine Phosphate Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Codeine Phosphate Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Codeine Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Codeine Phosphate Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Codeine Phosphate Injection Sales Value, 2019-2030
6.9.2 India Codeine Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Codeine Phosphate Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Nepharm
7.1.1 Nepharm Company Information
7.1.2 Nepharm Introduction and Business Overview
7.1.3 Nepharm Codeine Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Nepharm Codeine Phosphate Injection Product Offerings
7.1.5 Nepharm Recent Development
7.2 Humanwell Pharma
7.2.1 Humanwell Pharma Company Information
7.2.2 Humanwell Pharma Introduction and Business Overview
7.2.3 Humanwell Pharma Codeine Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Humanwell Pharma Codeine Phosphate Injection Product Offerings
7.2.5 Humanwell Pharma Recent Development
8 Industry Chain Analysis
8.1 Codeine Phosphate Injection Industrial Chain
8.2 Codeine Phosphate Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Codeine Phosphate Injection Sales Model
8.5.2 Sales Channel
8.5.3 Codeine Phosphate Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Nepharm
Humanwell Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂